Delivery Order SPE2DB22D9362-SPE2DB24FY24C

Award Date 6/28/24
Potential Completion Date 7/22/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $95,007.00 and covers the delivery of GAMMAGARD LIQUID 10% VIAL 200ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is worth $79,045.92 and runs through February 12, 2024. It is for the provision of GAMMAGARD LIQUID 10% VIAL 200ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of GAMMAGARD LIQUID 10% VIAL 50ML, a pharmaceutical product, with a ceiling value of $25,936.50. The contract has a firm fixed price and does not have a set-aside designation. The ultimate completion date for this delivery order is April 15, 2024. DMS Pharmaceutical Group Inc. holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $98,807.40, is for the delivery of GAMMAGARD LIQUID 10% VIAL 200ML, a specialized pharmaceutical product, with a completion date of February 7, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a $82,997.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for GAMMAGARD LIQUID 10% VIAL 200ML, a pharmaceutical product, with an ultimate completion date of April 1, 2024. This delivery order is placed against DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,665.68 firm fixed-price contract is for the supply of GAMMAGARD LIQUID 10% VIAL 200ML, with a completion date of March 6, 2024. This award is under DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with DLA, valued at up to $4,999,999 through 2025, which enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $165,994.08, is for the supply of GAMMAGARD LIQUID 10% VIAL 200ML, a pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,665.68 contract is for the delivery of 4565377038 - GAMMAGARD LIQUID 10% VIAL 200ML, with a period of performance through August 26, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $79,045.92 and has an ultimate completion date of February 22, 2023. It is for the delivery of GAMMAGARD LIQUID 10% VIAL 200ML, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, which allows DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,665.68 firm fixed-price contract is for the supply of GAMMAGARD LIQUID 10% VIAL 200ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. also holds a larger...
  • SPE2DB22D9362
    Indefinite Delivery Contract
  • SPE2DB22D9362-SPE2DB24FY24C
    Delivery Order

This is a $27,665.68 delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of GAMMAGARD LIQUID 10% VIAL 200ML, a pharmaceutical product, with a performance period through July 22, 2024.

DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This delivery order contract is one of the individual orders placed against that IDC vehicle to support the DLA's Medical Supply Chain program. The contract does not have a set-aside designation.

Generated 9/27/24, 9:36 AM